UK shares finish mixed as investors react to reports of merger discussions involving AstraZeneca, which weigh on parts of the market. According to the Belfast Telegraph and The Independent, the FTSE 100 index ends the session lower, though the overall move is modest and trading is not uniformly negative across the board. The Independent reports the FTSE 100 closes down 10.35 points, representing a decline of 0.1%, at 10,857.70. Belfast Telegraph similarly describes the market as mixed, with the AstraZeneca merger talk cited as a factor pressuring the index. While the specific details of the potential transaction are not outlined in the provided summaries, the common thread across both outlets is that news or speculation around the possible combination involving AstraZeneca affects investor sentiment and contributes to the day’s slight downturn in the benchmark. Overall, both sources characterize the decline as limited and consistent with a market that is adjusting to developing corporate news rather than a broad sell-off.